Disease_category,Disease,Protein,Protein_definition,method,nsnp,OR [95% CI],Pvalue,QTL_type
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,FCRLB,Fc receptor-like B,Inverse variance weighted,61,0.38 [0.24-0.6],2.86200117039269e-05,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,SEMA3F,Semaphorin-3F,Inverse variance weighted,15,0.05 [0.01-0.29],0.00082819870808675,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,4,14.52 [3-70.17],0.00087420727158966,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,PALM2,Paralemmin-2,Inverse variance weighted,8,0.25 [0.09-0.64],0.00416236690049506,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,25,0.61 [0.43-0.86],0.00473370751487883,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,GRN,Progranulin,Inverse variance weighted,7,0.38 [0.18-0.79],0.00922962769916537,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,SCG2,Secretogranin-2,Wald ratio,1,430.2 [3.53-52433.05],0.0133361900020402,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,ACY1,Aminoacylase-1,Inverse variance weighted,4,5.2 [1.34-20.15],0.016961172997093,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,MDK,Midkine,Inverse variance weighted,4,5.69 [1.32-24.61],0.0199244939254948,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,HIP1R,Huntingtin-interacting protein 1-related protein,Wald ratio,1,0.05 [0-0.63],0.0205143553491435,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,3,0.18 [0.04-0.77],0.0214001649510624,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,IL18R1,Interleukin-18 receptor 1,Inverse variance weighted,46,1.37 [1.05-1.8],0.0223688610727656,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,14,0.32 [0.12-0.88],0.0278223377986918,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,IL1RL1,Interleukin-1 receptor-like 1,Inverse variance weighted,44,1.47 [1.04-2.08],0.0281083704760245,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,22,0.56 [0.33-0.96],0.0347156278709205,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,LRRN1,Leucine-rich repeat neuronal protein 1,Inverse variance weighted,24,1.91 [1.04-3.52],0.0377888298845498,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,MMP12,Macrophage metalloelastase,Inverse variance weighted,18,0.7 [0.5-0.99],0.0413272648174153,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,PRSS8,Prostasin,Inverse variance weighted,5,4.82 [1.06-21.88],0.0414385291376697,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,21,0.22 [0.05-0.96],0.0433140666711888,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,CD83,CD83 antigen,Inverse variance weighted,5,0.31 [0.1-0.98],0.0453682582315277,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,Wald ratio,1,7.76 [1.02-59.22],0.0481168017998892,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,FABP3,"Fatty acid-binding protein, heart",Inverse variance weighted,4,6.87 [1.01-46.71],0.0488605655467353,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,RNASE4,Ribonuclease 4,Inverse variance weighted,11,1.88 [1-3.56],0.0513025233958422,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,MUC13,Mucin-13,Inverse variance weighted,9,3.41 [0.99-11.76],0.0518652588551735,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,VMO1,Vitelline membrane outer layer protein 1 homolog,Inverse variance weighted,34,1.33 [1-1.76],0.0526931505106488,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,PSAP,Prosaposin,Inverse variance weighted,5,0.38 [0.14-1.03],0.0569271319183858,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,TGFA,Protransforming growth factor alpha,Inverse variance weighted,2,6.15 [0.93-40.78],0.0598404501550212,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,PLA2G15,Phospholipase A2 group XV,Inverse variance weighted,12,1.7 [0.97-2.99],0.0640511106298389,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,MMP8,Neutrophil collagenase,Inverse variance weighted,17,1.54 [0.97-2.45],0.0697740212158812,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,VSIG2,V-set and immunoglobulin domain-containing protein 2,Inverse variance weighted,5,0.41 [0.15-1.09],0.0742983978970103,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,PCSK9,Proprotein convertase subtilisin/kexin type 9,Inverse variance weighted,5,2.08 [0.93-4.67],0.075726042282258,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,MME,Neprilysin,Inverse variance weighted,3,0.09 [0.01-1.37],0.0831157457231396,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,10,1.96 [0.88-4.35],0.0999311542511925,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,CD59,CD59 glycoprotein,Inverse variance weighted,4,2.14 [0.85-5.37],0.105143852419275,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,IL1R1,Interleukin-1 receptor type 1,Inverse variance weighted,7,2.23 [0.83-6.02],0.111849350922994,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",Inverse variance weighted,10,1.83 [0.86-3.9],0.115964152947107,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,2,3.45 [0.73-16.27],0.117210898930513,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,IGFBP4,Insulin-like growth factor-binding protein 4,Wald ratio,1,66.55 [0.32-13729.73],0.122613606894432,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,IL1RN,Interleukin-1 receptor antagonist protein,Inverse variance weighted,10,1.88 [0.82-4.32],0.134969758234984,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,NECTIN2,Nectin-2,Inverse variance weighted,5,1.65 [0.86-3.17],0.135179411809492,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,TFF3,Trefoil factor 3,Inverse variance weighted,5,2.73 [0.73-10.28],0.136476538354856,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,EGFR,Epidermal growth factor receptor,Inverse variance weighted,7,3.52 [0.67-18.62],0.13865149773328,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,ITGBL1,Integrin beta-like protein 1,Inverse variance weighted,23,0.67 [0.4-1.14],0.139035255739652,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,NELL1,Protein kinase C-binding protein NELL1,Inverse variance weighted,10,0.66 [0.37-1.16],0.145916507091751,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,6,0.75 [0.51-1.12],0.159231484362014,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,LECT2,Leukocyte cell-derived chemotaxin-2,Inverse variance weighted,44,1.27 [0.9-1.78],0.176093990065936,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,IGF2R,Cation-independent mannose-6-phosphate receptor,Inverse variance weighted,21,1.42 [0.85-2.4],0.18174796354118,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,CXCL16,C-X-C motif chemokine 16,Inverse variance weighted,8,2.13 [0.68-6.63],0.193027829380622,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,Inverse variance weighted,5,0.47 [0.15-1.49],0.201320256367963,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,Wald ratio,1,0.17 [0.01-2.68],0.207963960156624,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,Inverse variance weighted,20,0.63 [0.3-1.3],0.208226191919745,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,REG1A,Lithostathine-1-alpha,Inverse variance weighted,13,1.52 [0.79-2.93],0.210578330623672,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,PRAP1,Proline-rich acidic protein 1,Inverse variance weighted,7,0.65 [0.33-1.28],0.21119768060541,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,OCLN,Occludin,Inverse variance weighted,2,3 [0.53-16.96],0.213582891071269,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,NHLRC3,NHL repeat-containing protein 3,Inverse variance weighted,8,1.72 [0.72-4.1],0.223090826235045,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,13,1.39 [0.82-2.35],0.223275257478872,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,SPON2,Spondin-2,Inverse variance weighted,4,1.78 [0.67-4.71],0.246856247508544,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",Inverse variance weighted,8,0.54 [0.19-1.56],0.255535503260214,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,EPO,Erythropoietin,Inverse variance weighted,5,0.22 [0.02-3.12],0.265277158250434,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,ADAMTSL2,ADAMTS-like protein 2,Inverse variance weighted,4,2.76 [0.46-16.51],0.266307947579371,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,Inverse variance weighted,7,0.6 [0.24-1.48],0.268474207737466,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,CD80,T-lymphocyte activation antigen CD80,Inverse variance weighted,16,0.78 [0.49-1.22],0.275954158536859,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,15,1.38 [0.77-2.47],0.276435942245551,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,MMP7,Matrilysin,Inverse variance weighted,13,0.69 [0.35-1.36],0.281157051657151,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,DLL1,Delta-like protein 1,Inverse variance weighted,7,0.55 [0.18-1.65],0.284006424180547,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,SIGLEC1,Sialoadhesin,Inverse variance weighted,20,1.33 [0.78-2.26],0.287988910676184,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,ITGA11,Integrin alpha-11,Inverse variance weighted,8,0.65 [0.3-1.43],0.288113757396101,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,CLEC14A,C-type lectin domain family 14 member A,Wald ratio,1,0.23 [0.02-3.46],0.289144834537885,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,CHGA,Chromogranin-A,Inverse variance weighted,3,0.54 [0.17-1.7],0.290788598561426,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,CD300E,CMRF35-like molecule 2,Inverse variance weighted,21,0.76 [0.46-1.26],0.293551302715609,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,25,0.8 [0.52-1.23],0.308290389997252,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,GPRC5C,G-protein coupled receptor family C group 5 member C,Wald ratio,1,0.36 [0.05-2.57],0.308293319381445,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,GRPEL1,"GrpE protein homolog 1, mitochondrial",Wald ratio,1,8.72 [0.13-569.4],0.309829595396103,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,CCDC80,Coiled-coil domain-containing protein 80,Inverse variance weighted,3,0.3 [0.03-3.05],0.312130659606413,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,CCL20,C-C motif chemokine 20,Inverse variance weighted,2,0.27 [0.02-3.59],0.318048512356313,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,4,0.58 [0.2-1.72],0.325571082608916,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,REN,Renin,Inverse variance weighted,4,2.2 [0.45-10.78],0.329251294094026,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,AREG,Amphiregulin,Inverse variance weighted,3,0.49 [0.12-2.11],0.339501868921275,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,7,1.74 [0.55-5.49],0.343095864209896,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,5,0.53 [0.14-2.02],0.347939285204236,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,5,2.09 [0.44-9.93],0.351821289525759,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,OSM,Oncostatin-M,Wald ratio,1,0.22 [0.01-5.42],0.352998390860073,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,CCL15,C-C motif chemokine 15,Inverse variance weighted,22,1.17 [0.84-1.64],0.362250563532669,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,FAM3C,Protein FAM3C,Inverse variance weighted,2,0.17 [0-8.36],0.372261050045298,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,MZB1,Marginal zone B- and B1-cell-specific protein,Wald ratio,1,0.07 [0-26.86],0.374294943397704,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,LAYN,Layilin,Inverse variance weighted,20,1.39 [0.67-2.86],0.375852925627638,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,PVR,Poliovirus receptor,Inverse variance weighted,27,0.87 [0.64-1.19],0.377770939755084,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,CCN3,CCN family member 3,Inverse variance weighted,19,0.72 [0.35-1.49],0.380538008168344,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,PLA2G7,Platelet-activating factor acetylhydrolase,Inverse variance weighted,2,11.59 [0.04-3075.78],0.389487445883448,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,RNASET2,Ribonuclease T2,Inverse variance weighted,14,1.24 [0.75-2.03],0.398009626854654,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,CHCHD6,MICOS complex subunit MIC25,Inverse variance weighted,4,0.69 [0.28-1.67],0.406350336644315,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,SERPIND1,Heparin cofactor 2,Wald ratio,1,3.35 [0.19-59.01],0.408082538572305,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,19,0.79 [0.44-1.4],0.411784352683622,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,MFGE8,Lactadherin,Inverse variance weighted,11,1.31 [0.68-2.53],0.416887222000426,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,FGF23,Fibroblast growth factor 23,Inverse variance weighted,2,0.46 [0.07-3.08],0.425505601764799,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,15,0.79 [0.44-1.42],0.429123682627295,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,COL4A1,Collagen alpha-1(IV) chain,Inverse variance weighted,3,1.64 [0.48-5.58],0.431783805309957,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,ADGRD1,Adhesion G-protein coupled receptor D1,Inverse variance weighted,22,1.16 [0.8-1.66],0.434385069882094,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,REG1B,Lithostathine-1-beta,Inverse variance weighted,18,1.24 [0.73-2.1],0.43660338393975,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,2,0.51 [0.09-2.87],0.445276504970044,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,MVK,Mevalonate kinase,Inverse variance weighted,2,0.35 [0.02-5.25],0.447414340689613,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,LGALS4,Galectin-4,Inverse variance weighted,4,0.58 [0.14-2.37],0.449028363422239,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,RRM2,Ribonucleoside-diphosphate reductase subunit M2,Wald ratio,1,5.87 [0.06-573.02],0.449122291647578,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,CDH2,Cadherin-2,Inverse variance weighted,3,5.12 [0.07-367.5],0.453749859808558,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,SPINK4,Serine protease inhibitor Kazal-type 4,Inverse variance weighted,29,0.89 [0.65-1.21],0.464432008142013,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,HGF,Hepatocyte growth factor,Inverse variance weighted,2,0.28 [0.01-8.84],0.469082071466451,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,22,0.82 [0.47-1.42],0.47110319772463,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,10,0.82 [0.47-1.42],0.477419493115665,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,CCL3,C-C motif chemokine 3,Inverse variance weighted,9,1.28 [0.64-2.55],0.482263271977108,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,Inverse variance weighted,16,0.82 [0.48-1.42],0.484988684026813,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,NFASC,Neurofascin,Inverse variance weighted,15,1.21 [0.7-2.11],0.488246660678263,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,3,2.87 [0.14-57.72],0.491237710562764,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,MRC1,Macrophage mannose receptor 1,Inverse variance weighted,7,1.59 [0.42-6.01],0.491298370198759,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,CSTB,Cystatin-B,Inverse variance weighted,28,1.17 [0.75-1.82],0.492146217069126,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,SMPD1,Sphingomyelin phosphodiesterase,Inverse variance weighted,13,1.5 [0.45-5.03],0.508297753849039,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,INHBB,Inhibin beta B chain,Inverse variance weighted,10,0.81 [0.43-1.52],0.510485160960685,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,FABP4,"Fatty acid-binding protein, adipocyte",Wald ratio,1,0.41 [0.03-6.04],0.519327322475253,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,CTSZ,Cathepsin Z,Inverse variance weighted,3,0.79 [0.38-1.63],0.521661042452138,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,6,0.72 [0.26-1.98],0.524927240256159,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,5,1.34 [0.54-3.31],0.525666851862706,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,6,1.39 [0.49-3.93],0.530838288027702,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,EDN1,Endothelin-1,Inverse variance weighted,3,1.38 [0.5-3.78],0.531941479334139,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,2,0.53 [0.07-3.93],0.533515350041037,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,PTN,Pleiotrophin,Inverse variance weighted,4,0.55 [0.08-3.71],0.535944508719592,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,IL19,Interleukin-19,Inverse variance weighted,11,1.25 [0.61-2.53],0.542807078867278,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Wald ratio,1,1.82 [0.26-12.83],0.54949609471243,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,23,0.89 [0.6-1.32],0.555540486485565,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,YAP1,Transcriptional coactivator YAP1,Wald ratio,1,2.95 [0.08-108.79],0.556718206005842,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,SFRP1,Secreted frizzled-related protein 1,Inverse variance weighted,13,0.79 [0.36-1.74],0.559341755462136,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,MSR1,Macrophage scavenger receptor types I and II,Inverse variance weighted,8,0.84 [0.47-1.51],0.559881301820315,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,2,0.3 [0.01-17.23],0.562529653265779,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,AMBP,Protein AMBP,Inverse variance weighted,3,0.64 [0.14-2.94],0.568067792428637,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,CST3,Cystatin-C,Inverse variance weighted,10,1.24 [0.6-2.56],0.570025340958875,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,14,0.86 [0.5-1.47],0.5792309410132,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,CD27,CD27 antigen,Inverse variance weighted,9,1.23 [0.58-2.61],0.588056781725875,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,ICAM1,Intercellular adhesion molecule 1,Inverse variance weighted,28,1.12 [0.74-1.72],0.591088948450683,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,SMOC2,SPARC-related modular calcium-binding protein 2,Inverse variance weighted,17,0.87 [0.52-1.47],0.608064615211917,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,VWA1,von Willebrand factor A domain-containing protein 1,Inverse variance weighted,6,0.84 [0.43-1.64],0.609348646876366,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,RARRES2,Retinoic acid receptor responder protein 2,Inverse variance weighted,2,1.53 [0.29-8.05],0.612854764827211,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,7,0.68 [0.15-3.1],0.616741503491353,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,AGXT,Serine--pyruvate aminotransferase,Inverse variance weighted,10,1.19 [0.6-2.35],0.626100385327034,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,PI3,Elafin,Inverse variance weighted,10,0.85 [0.43-1.66],0.627300733058732,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,Inverse variance weighted,10,1.27 [0.48-3.31],0.629217618580185,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,DKK4,Dickkopf-related protein 4,Inverse variance weighted,4,0.66 [0.12-3.64],0.633333374122358,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,Inverse variance weighted,4,1.51 [0.28-8.12],0.634519577989384,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,FGL1,Fibrinogen-like protein 1,Inverse variance weighted,30,0.91 [0.61-1.35],0.635594530240566,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,EFNA4,Ephrin-A4,Inverse variance weighted,3,0.46 [0.02-11.51],0.636271483066645,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",Inverse variance weighted,3,1.44 [0.32-6.54],0.638896456506431,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,KLK4,Kallikrein-4,Inverse variance weighted,17,1.14 [0.65-2.02],0.641706878556615,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,RNASE6,Ribonuclease K6,Inverse variance weighted,15,0.87 [0.49-1.56],0.642234604807375,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,BTN2A1,Butyrophilin subfamily 2 member A1,Wald ratio,1,0.57 [0.05-6.33],0.6436442476426,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,25,0.9 [0.57-1.42],0.653876893585842,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,OSCAR,Osteoclast-associated immunoglobulin-like receptor,Inverse variance weighted,24,0.92 [0.65-1.31],0.657996909307222,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,LCN2,Neutrophil gelatinase-associated lipocalin,Wald ratio,1,3.9 [0.01-1648.17],0.658859513360151,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,CPM,Carboxypeptidase M,Inverse variance weighted,4,1.51 [0.24-9.44],0.662202418748411,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,36,0.92 [0.65-1.32],0.666336189160737,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,CXCL13,C-X-C motif chemokine 13,Wald ratio,1,2.45 [0.04-149.39],0.669996843725987,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,CA9,Carbonic anhydrase 9,Inverse variance weighted,3,0.7 [0.13-3.64],0.671762234866808,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,COLEC12,Collectin-12,Inverse variance weighted,11,1.21 [0.49-2.95],0.677082889891621,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,46,0.95 [0.73-1.23],0.678424323430775,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,CHI3L1,Chitinase-3-like protein 1,Inverse variance weighted,21,0.93 [0.66-1.31],0.678812278212684,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,5,1.23 [0.46-3.3],0.681758964631819,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,CCL21,C-C motif chemokine 21,Inverse variance weighted,4,1.46 [0.21-10.37],0.705278293277308,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,CD14,Monocyte differentiation antigen CD14,Inverse variance weighted,13,1.18 [0.49-2.84],0.705826150649652,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,16,1.15 [0.55-2.44],0.7080939403721,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,10,0.87 [0.42-1.8],0.715045675631216,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,EPHB4,Ephrin type-B receptor 4,Wald ratio,1,1.31 [0.3-5.66],0.717703594810153,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,IL17C,Interleukin-17C,Inverse variance weighted,3,0.74 [0.14-3.88],0.720793448533018,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,10,1.17 [0.5-2.71],0.720995567281912,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,CLEC5A,C-type lectin domain family 5 member A,Inverse variance weighted,8,1.14 [0.55-2.34],0.721069129257151,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,FGF21,Fibroblast growth factor 21,Inverse variance weighted,2,1.57 [0.13-19.04],0.721852648841886,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,2,0.76 [0.17-3.45],0.725847571543177,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,NPPB,Natriuretic peptides B,Inverse variance weighted,3,0.78 [0.19-3.17],0.726471336162504,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,7,1.18 [0.46-3],0.72760461287649,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,ADM,Pro-adrenomedullin,Inverse variance weighted,2,1.45 [0.17-12.29],0.730536255042912,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,SEPTIN8,Septin-8,Inverse variance weighted,2,1.32 [0.27-6.59],0.732071707345087,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,ACTA2,"Actin, aortic smooth muscle",Wald ratio,1,0.52 [0.01-21.71],0.73215554949384,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",Inverse variance weighted,8,1.17 [0.48-2.87],0.733745919589306,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,20,0.94 [0.64-1.37],0.734879813432642,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,FAM20A,Pseudokinase FAM20A,Inverse variance weighted,14,1.11 [0.59-2.09],0.735742268471445,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,DTX3,Probable E3 ubiquitin-protein ligase DTX3,Inverse variance weighted,3,0.7 [0.08-5.74],0.735828865405632,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,2,2.11 [0.03-166.51],0.736844531460291,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,7,0.87 [0.38-1.98],0.737932008093927,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,10,0.88 [0.42-1.85],0.743559676638137,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,SIGLEC7,Sialic acid-binding Ig-like lectin 7,Inverse variance weighted,10,0.86 [0.33-2.2],0.745757224311875,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,PGA4,Pepsin A-4,Inverse variance weighted,2,0.6 [0.03-12.76],0.746134928200203,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,KRT19,"Keratin, type I cytoskeletal 19",Wald ratio,1,0.77 [0.16-3.79],0.747368673686486,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,CD79B,B-cell antigen receptor complex-associated protein beta chain,Inverse variance weighted,2,1.25 [0.32-4.8],0.747735762165401,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,10,1.11 [0.57-2.17],0.752511440363596,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,GDF15,Growth/differentiation factor 15,Inverse variance weighted,12,0.81 [0.22-2.97],0.753470589212766,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,BST2,Bone marrow stromal antigen 2,Inverse variance weighted,2,1.17 [0.43-3.2],0.755259878184679,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,CBLIF,Cobalamin binding intrinsic factor,Inverse variance weighted,2,0.68 [0.06-8.08],0.759107598893562,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,Inverse variance weighted,4,1.36 [0.18-10.09],0.766297239059561,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,FGFBP1,Fibroblast growth factor-binding protein 1,Inverse variance weighted,5,1.22 [0.32-4.59],0.771187298384372,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Inverse variance weighted,6,0.81 [0.19-3.44],0.775312778051321,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,ANGPTL4,Angiopoietin-related protein 4,Inverse variance weighted,7,1.15 [0.42-3.19],0.784091721325735,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,GGT1,Glutathione hydrolase 1 proenzyme,Inverse variance weighted,10,0.88 [0.37-2.14],0.784765762230544,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,5,0.9 [0.42-1.92],0.786545751297265,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,SIGLEC10,Sialic acid-binding Ig-like lectin 10,Inverse variance weighted,14,1.06 [0.71-1.56],0.789406747757477,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,PLXNB2,Plexin-B2,Inverse variance weighted,27,0.96 [0.69-1.33],0.796126893076503,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Wald ratio,1,2.16 [0.01-792.31],0.797849512579579,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,GSN,Gelsolin,Inverse variance weighted,5,1.26 [0.2-7.86],0.806870013087381,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,IL15,Interleukin-15,Wald ratio,1,0.08 [0-111027112.1],0.810761474005625,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,NPL,N-acetylneuraminate lyase,Inverse variance weighted,11,1.11 [0.47-2.61],0.812844329677823,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,DNER,Delta and Notch-like epidermal growth factor-related receptor,Inverse variance weighted,12,1.09 [0.53-2.25],0.814509876302726,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,IGSF3,Immunoglobulin superfamily member 3,Inverse variance weighted,2,1.31 [0.13-12.94],0.819770324901463,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,LGALS9,Galectin-9,Inverse variance weighted,26,0.95 [0.59-1.53],0.820525983481,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,14,1.08 [0.55-2.09],0.825618980884984,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,REG4,Regenerating islet-derived protein 4,Inverse variance weighted,6,0.88 [0.27-2.82],0.831266376622639,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,TPP1,Tripeptidyl-peptidase 1,Inverse variance weighted,6,0.84 [0.17-4.09],0.831659434037139,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,LMNB2,Lamin-B2,Wald ratio,1,1.81 [0.01-537.25],0.837900239254173,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,EFNA1,Ephrin-A1,Inverse variance weighted,11,1.07 [0.56-2.03],0.839798155693346,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,SULT2A1,Bile salt sulfotransferase,Inverse variance weighted,4,0.92 [0.41-2.06],0.840762591480372,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,CFI,Complement factor I,Inverse variance weighted,6,1.13 [0.34-3.83],0.841321159183367,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,UMOD,Uromodulin,Inverse variance weighted,29,1.03 [0.77-1.37],0.84699339620777,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,3,1.27 [0.1-15.49],0.851915961653365,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Inverse variance weighted,41,0.98 [0.77-1.24],0.853199759015936,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,5,1.06 [0.56-2],0.854104800640171,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,CXADR,Coxsackievirus and adenovirus receptor,Inverse variance weighted,2,0.8 [0.08-8.21],0.854296126005811,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,27,0.96 [0.61-1.51],0.859535173059565,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,SHISA5,Protein shisa-5,Inverse variance weighted,5,0.82 [0.08-8.02],0.866921381485431,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,4,0.89 [0.21-3.79],0.869442395489141,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,TFF1,Trefoil factor 1,Inverse variance weighted,8,0.93 [0.39-2.2],0.869938000192256,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,AGRN,Agrin,Inverse variance weighted,17,0.95 [0.48-1.86],0.872165857393385,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,CCL16,C-C motif chemokine 16,Inverse variance weighted,19,1.03 [0.75-1.39],0.873279369516399,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,GM2A,Ganglioside GM2 activator,Inverse variance weighted,24,0.97 [0.68-1.39],0.885486581597848,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,9,1.06 [0.5-2.23],0.888258515622183,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,THBS2,Thrombospondin-2,Inverse variance weighted,16,1.05 [0.55-2],0.891914931920575,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,CDCP1,CUB domain-containing protein 1,Inverse variance weighted,14,0.95 [0.47-1.93],0.895158825278267,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,SPON1,Spondin-1,Inverse variance weighted,21,0.96 [0.55-1.68],0.898771232851082,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,BMPER,BMP-binding endothelial regulator protein,Inverse variance weighted,7,0.95 [0.42-2.14],0.899749185211783,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,FSTL3,Follistatin-related protein 3,Inverse variance weighted,4,1.14 [0.14-9.36],0.903374506257911,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,C7,Complement component C7,Inverse variance weighted,38,1.02 [0.78-1.33],0.908310955780845,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,12,0.95 [0.4-2.26],0.908937167981977,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,HYAL1,Hyaluronidase-1,Inverse variance weighted,5,1.05 [0.47-2.35],0.911486410463641,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,CD74,HLA class II histocompatibility antigen gamma chain,Wald ratio,1,0.76 [0-132.03],0.915684105007394,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,HSPB6,Heat shock protein beta-6,Wald ratio,1,1.35 [0-403.46],0.918134605533811,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,ADGRG1,Adhesion G-protein coupled receptor G1,Inverse variance weighted,5,1.1 [0.16-7.38],0.919478395470768,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,CD302,CD302 antigen,Inverse variance weighted,9,1.04 [0.48-2.22],0.925279872509205,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,PYY,Peptide YY,Inverse variance weighted,6,0.95 [0.29-3.14],0.929809122136214,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,PGF,Placenta growth factor,Inverse variance weighted,2,0.6 [0-104712.45],0.933497224054675,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,IL10,Interleukin-10,Wald ratio,1,1.1 [0.12-9.97],0.934922346940103,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,CTSL,Cathepsin L1,Wald ratio,1,1.22 [0.01-166.3],0.937942878988963,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,6,1.03 [0.43-2.5],0.941942415393721,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,Inverse variance weighted,4,1.04 [0.35-3.09],0.943003248320045,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,21,1.01 [0.6-1.7],0.95577657400978,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,KRT18,"Keratin, type I cytoskeletal 18",Wald ratio,1,1.15 [0.01-145.89],0.955841479881925,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,TFF2,Trefoil factor 2,Inverse variance weighted,5,1.05 [0.17-6.48],0.956379508047452,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,MFAP4,Microfibril-associated glycoprotein 4,Inverse variance weighted,4,1.04 [0.24-4.53],0.962112692236313,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,CTSD,Cathepsin D,Inverse variance weighted,17,1.01 [0.51-2.02],0.978434414664607,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,2,1.02 [0.28-3.73],0.980630208712904,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,IGSF8,Immunoglobulin superfamily member 8,Inverse variance weighted,2,1.02 [0.21-4.86],0.984463022914056,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,TREM2,Triggering receptor expressed on myeloid cells 2,Inverse variance weighted,4,1.01 [0.46-2.21],0.98518575537827,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Wald ratio,1,0.98 [0.03-36.34],0.992017656580789,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,ANGPT2,Angiopoietin-2,Inverse variance weighted,4,1 [0.25-3.97],0.996676350335141,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,PALM2,Paralemmin-2,Inverse variance weighted,9,0.25 [0.1-0.6],0.00198628449467685,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,31,0.62 [0.44-0.87],0.00562325016168619,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,PLA2G15,Phospholipase A2 group XV,Inverse variance weighted,20,2.86 [1.33-6.15],0.00693240280787489,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,CCL21,C-C motif chemokine 21,Inverse variance weighted,15,4.31 [1.41-13.17],0.0103479853707777,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,IL19,Interleukin-19,Inverse variance weighted,10,2.11 [1.14-3.91],0.0168233700951469,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,ITGBL1,Integrin beta-like protein 1,Inverse variance weighted,5,0.07 [0.01-0.66],0.0194225426804595,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,ACE2,Angiotensin-converting enzyme 2,Inverse variance weighted,11,5.82 [1.25-27.18],0.0250578475184455,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,IGSF3,Immunoglobulin superfamily member 3,Inverse variance weighted,4,13.78 [1.35-140.38],0.0267767772386487,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,CTSZ,Cathepsin Z,Inverse variance weighted,16,0.58 [0.36-0.95],0.0303000693971868,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,7,0.18 [0.04-0.87],0.0333969127091701,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,CD83,CD83 antigen,Inverse variance weighted,14,0.29 [0.09-0.92],0.0350016243187441,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,LCN2,Neutrophil gelatinase-associated lipocalin,Inverse variance weighted,21,0.39 [0.17-0.94],0.0356511206886863,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,13,3.49 [1.08-11.27],0.0363923321760472,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,SPON1,Spondin-1,Inverse variance weighted,4,11.55 [1.13-117.68],0.0388828564142953,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,CD79B,B-cell antigen receptor complex-associated protein beta chain,Inverse variance weighted,21,2.3 [1.04-5.09],0.0390495737262485,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",Inverse variance weighted,24,2.55 [1.01-6.42],0.0469686360318232,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,NFASC,Neurofascin,Inverse variance weighted,6,8.45 [0.99-72.12],0.0511518489849687,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,TREM2,Triggering receptor expressed on myeloid cells 2,Inverse variance weighted,35,1.58 [0.99-2.53],0.057408792410823,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,LECT2,Leukocyte cell-derived chemotaxin-2,Inverse variance weighted,11,0.26 [0.06-1.07],0.0626133355045828,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,ITGA11,Integrin alpha-11,Inverse variance weighted,7,0.29 [0.08-1.07],0.0631561546393859,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,MSR1,Macrophage scavenger receptor types I and II,Inverse variance weighted,18,0.39 [0.15-1.06],0.0646375551860267,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,10,4.72 [0.9-24.75],0.0665375946120115,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,SIGLEC1,Sialoadhesin,Inverse variance weighted,16,0.41 [0.15-1.07],0.0677760754310626,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,CD302,CD302 antigen,Inverse variance weighted,11,0.37 [0.12-1.08],0.0695576540661808,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,20,2.21 [0.89-5.51],0.0878908122311682,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,GGT1,Glutathione hydrolase 1 proenzyme,Inverse variance weighted,6,6.99 [0.72-68.19],0.0942789171917717,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,GPRC5C,G-protein coupled receptor family C group 5 member C,Inverse variance weighted,7,0.31 [0.08-1.25],0.0997140549387153,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,DLL1,Delta-like protein 1,Inverse variance weighted,6,0.17 [0.02-1.42],0.101837763991222,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,27,0.67 [0.41-1.09],0.105325380385369,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,5,5.77 [0.68-48.69],0.107553266591065,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,SMPD1,Sphingomyelin phosphodiesterase,Inverse variance weighted,20,0.56 [0.27-1.14],0.107623848970797,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,ADGRG2,Adhesion G-protein coupled receptor G2,Inverse variance weighted,8,4.83 [0.7-33.43],0.110330407424101,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,PSAP,Prosaposin,Inverse variance weighted,13,0.55 [0.26-1.15],0.11197756727412,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,7,4.6 [0.68-31.12],0.11766397642216,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,INHBB,Inhibin beta B chain,Inverse variance weighted,11,4.22 [0.69-25.89],0.119943505786766,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,MMP8,Neutrophil collagenase,Inverse variance weighted,10,2.44 [0.79-7.54],0.121138477650257,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,Inverse variance weighted,6,0.15 [0.01-1.7],0.126324316398024,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Inverse variance weighted,14,3.99 [0.67-23.79],0.128424983011319,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,ICAM1,Intercellular adhesion molecule 1,Inverse variance weighted,4,5.99 [0.59-60.31],0.128748451365409,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,IL18R1,Interleukin-18 receptor 1,Inverse variance weighted,22,1.63 [0.87-3.05],0.129209425223534,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,CD27,CD27 antigen,Inverse variance weighted,9,3.66 [0.68-19.59],0.129982680624232,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,COLEC12,Collectin-12,Inverse variance weighted,3,23.25 [0.39-1394.86],0.132003468966389,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,B2M,Beta-2-microglobulin,Inverse variance weighted,7,5.35 [0.59-48.98],0.137410042951486,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,SPINK4,Serine protease inhibitor Kazal-type 4,Inverse variance weighted,14,2.38 [0.74-7.66],0.144554001935103,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,IL17C,Interleukin-17C,Inverse variance weighted,5,0.19 [0.02-1.76],0.144852213299196,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,13,2.98 [0.69-12.92],0.145468269059661,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,PGF,Placenta growth factor,Inverse variance weighted,5,3.82 [0.61-24.09],0.153125734599617,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,CDCP1,CUB domain-containing protein 1,Inverse variance weighted,9,2.28 [0.73-7.12],0.154082443558186,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,REG1B,Lithostathine-1-beta,Inverse variance weighted,7,0.28 [0.05-1.63],0.155562470980443,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,IL10,Interleukin-10,Inverse variance weighted,4,0.5 [0.19-1.31],0.156663981874984,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,FGF23,Fibroblast growth factor 23,Inverse variance weighted,15,2.24 [0.73-6.88],0.1583874779146,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,PRAP1,Proline-rich acidic protein 1,Inverse variance weighted,8,0.62 [0.32-1.21],0.158902860590586,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,CD74,HLA class II histocompatibility antigen gamma chain,Inverse variance weighted,7,2.54 [0.69-9.37],0.160667796283302,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,CHGA,Chromogranin-A,Inverse variance weighted,5,3.27 [0.61-17.54],0.166782152447422,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,CCL3,C-C motif chemokine 3,Inverse variance weighted,15,1.56 [0.83-2.93],0.167064125647003,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,EDA2R,Tumor necrosis factor receptor superfamily member 27,Inverse variance weighted,12,2.88 [0.62-13.42],0.177283477766671,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,REG1A,Lithostathine-1-alpha,Inverse variance weighted,13,0.55 [0.23-1.32],0.179235560025817,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,CLEC5A,C-type lectin domain family 5 member A,Inverse variance weighted,10,0.49 [0.17-1.42],0.187481662778211,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,RNASET2,Ribonuclease T2,Inverse variance weighted,10,0.43 [0.12-1.53],0.193067178439752,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,GDF15,Growth/differentiation factor 15,Wald ratio,1,79.67 [0.1-61104.77],0.196434627567751,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,C7,Complement component C7,Inverse variance weighted,26,0.71 [0.41-1.2],0.197107961551087,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,EPHB4,Ephrin type-B receptor 4,Inverse variance weighted,9,2.12 [0.67-6.68],0.198622604742418,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,Inverse variance weighted,5,0.47 [0.15-1.49],0.201320256367963,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,ADAMTSL2,ADAMTS-like protein 2,Inverse variance weighted,9,2.17 [0.66-7.19],0.202761717030181,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,FCRLB,Fc receptor-like B,Inverse variance weighted,10,0.42 [0.11-1.62],0.206586982259861,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,DTX3,Probable E3 ubiquitin-protein ligase DTX3,Inverse variance weighted,13,0.56 [0.23-1.4],0.217396173653055,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,SEMA3F,Semaphorin-3F,Inverse variance weighted,32,0.62 [0.29-1.33],0.222139710195721,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,LGALS4,Galectin-4,Inverse variance weighted,15,1.43 [0.8-2.56],0.229283912335095,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,HGF,Hepatocyte growth factor,Inverse variance weighted,5,0.27 [0.03-2.31],0.231147158078223,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,8,2.29 [0.57-9.27],0.243456417485166,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,IL6,Interleukin-6,Inverse variance weighted,6,0.56 [0.21-1.49],0.247391742539353,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,CBLIF,Cobalamin binding intrinsic factor,Inverse variance weighted,57,0.82 [0.59-1.15],0.24864600584862,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,FGFBP1,Fibroblast growth factor-binding protein 1,Inverse variance weighted,12,0.51 [0.16-1.61],0.252653235620069,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,FGF21,Fibroblast growth factor 21,Inverse variance weighted,2,0.14 [0-4.54],0.270186099706553,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,6,3.87 [0.34-43.78],0.274345292364014,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,BST2,Bone marrow stromal antigen 2,Inverse variance weighted,24,1.81 [0.61-5.35],0.286106653932464,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,EPO,Erythropoietin,Inverse variance weighted,11,1.74 [0.63-4.8],0.287040053797187,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,3,5.28 [0.24-115.75],0.290699500457901,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,10,2.29 [0.48-10.93],0.297816093211282,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,FAM3C,Protein FAM3C,Inverse variance weighted,3,0.28 [0.02-3.17],0.30292664431123,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,CCDC80,Coiled-coil domain-containing protein 80,Inverse variance weighted,10,0.49 [0.12-1.93],0.30523922499802,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,IL22,Interleukin-22,Inverse variance weighted,4,4.27 [0.27-68.53],0.305769756069986,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,ANGPTL4,Angiopoietin-related protein 4,Wald ratio,1,17.59 [0.07-4501.01],0.310749610026034,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,PTN,Pleiotrophin,Inverse variance weighted,3,0.28 [0.02-3.27],0.312310642167412,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,6,3.09 [0.34-27.96],0.315426903595781,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,TPP1,Tripeptidyl-peptidase 1,Inverse variance weighted,11,0.51 [0.13-1.94],0.322106037229677,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,7,2.04 [0.49-8.51],0.328031596731157,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,VSIG4,V-set and immunoglobulin domain-containing protein 4,Inverse variance weighted,12,2.04 [0.49-8.61],0.329700309184806,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,12,0.46 [0.1-2.2],0.33234185889885,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,4,0.41 [0.07-2.51],0.335402810004059,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,KRT18,"Keratin, type I cytoskeletal 18",Inverse variance weighted,7,0.42 [0.07-2.5],0.341946502717459,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,9,0.4 [0.06-2.65],0.345209124220767,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,CCL15,C-C motif chemokine 15,Inverse variance weighted,28,1.14 [0.86-1.52],0.348375092598282,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,CPM,Carboxypeptidase M,Inverse variance weighted,19,1.85 [0.51-6.76],0.34907928141282,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,VWA1,von Willebrand factor A domain-containing protein 1,Inverse variance weighted,5,0.19 [0.01-6.6],0.356913054390173,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,3,0.21 [0.01-5.87],0.361495219092239,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,Inverse variance weighted,9,0.42 [0.06-2.78],0.366826644130246,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,BMPER,BMP-binding endothelial regulator protein,Inverse variance weighted,4,2.74 [0.29-25.97],0.37920636829719,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,REG4,Regenerating islet-derived protein 4,Inverse variance weighted,13,0.53 [0.12-2.23],0.384091517944168,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,CHI3L1,Chitinase-3-like protein 1,Inverse variance weighted,5,0.36 [0.04-3.59],0.38463231888345,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,GAST,Gastrin,Inverse variance weighted,9,1.75 [0.49-6.24],0.389393861069356,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,KLK4,Kallikrein-4,Inverse variance weighted,5,0.29 [0.02-4.97],0.395384992946436,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,CCN3,CCN family member 3,Inverse variance weighted,17,0.75 [0.38-1.46],0.396098983323533,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,10,0.54 [0.12-2.36],0.409669352990944,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,VMO1,Vitelline membrane outer layer protein 1 homolog,Inverse variance weighted,8,2.06 [0.36-11.69],0.414843315131555,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,LRRN1,Leucine-rich repeat neuronal protein 1,Inverse variance weighted,12,2.18 [0.33-14.37],0.417261667584176,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,EFNA1,Ephrin-A1,Inverse variance weighted,3,0.38 [0.04-3.93],0.420281916940188,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,CXADR,Coxsackievirus and adenovirus receptor,Inverse variance weighted,13,1.74 [0.44-6.95],0.430716102522412,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,IL1R1,Interleukin-1 receptor type 1,Inverse variance weighted,14,0.63 [0.2-2.01],0.434394644643384,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,11,0.42 [0.05-3.75],0.435564405561245,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,HSPB6,Heat shock protein beta-6,Inverse variance weighted,4,0.42 [0.05-3.77],0.435623983146081,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,IGF2R,Cation-independent mannose-6-phosphate receptor,Inverse variance weighted,19,0.62 [0.19-2.05],0.437024492234129,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,SMOC2,SPARC-related modular calcium-binding protein 2,Inverse variance weighted,11,0.56 [0.13-2.47],0.439993207492361,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,AGXT,Serine--pyruvate aminotransferase,Inverse variance weighted,12,1.82 [0.39-8.49],0.444433525252512,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,21,0.67 [0.23-1.92],0.455446345701701,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,CFI,Complement factor I,Wald ratio,1,14.23 [0.01-15290.58],0.455853593209924,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,CD300E,CMRF35-like molecule 2,Inverse variance weighted,35,0.84 [0.52-1.34],0.457501101911231,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,SIGLEC7,Sialic acid-binding Ig-like lectin 7,Inverse variance weighted,6,1.91 [0.34-10.61],0.459985932720487,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,ANGPT2,Angiopoietin-2,Inverse variance weighted,7,0.52 [0.09-2.98],0.46150410860311,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,CXCL13,C-X-C motif chemokine 13,Wald ratio,1,0.15 [0-24.78],0.461824710486445,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,ACY1,Aminoacylase-1,Inverse variance weighted,6,0.56 [0.11-2.71],0.467520542295666,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,3,0.38 [0.03-5.36],0.470508432162039,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,10,1.98 [0.31-12.89],0.473575132442749,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,LMNB2,Lamin-B2,Inverse variance weighted,8,0.54 [0.1-2.94],0.473921031386469,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,PGA4,Pepsin A-4,Inverse variance weighted,7,0.53 [0.09-3.02],0.477175922685427,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,CSTB,Cystatin-B,Inverse variance weighted,23,1.19 [0.74-1.93],0.477648816500377,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,CDH2,Cadherin-2,Inverse variance weighted,21,1.45 [0.52-4.07],0.479272680369348,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,Inverse variance weighted,3,0.57 [0.12-2.77],0.482284908488909,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,TFF2,Trefoil factor 2,Inverse variance weighted,16,0.7 [0.26-1.88],0.483994460691635,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,RBFOX3,RNA binding protein fox-1 homolog 3,Inverse variance weighted,2,4.02 [0.08-203.35],0.48676548756103,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,PCSK9,Proprotein convertase subtilisin/kexin type 9,Inverse variance weighted,9,1.74 [0.36-8.33],0.487914099089937,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,6,0.51 [0.07-3.51],0.491184748071452,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,MRC1,Macrophage mannose receptor 1,Inverse variance weighted,17,0.68 [0.22-2.06],0.493194415371665,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,MVK,Mevalonate kinase,Wald ratio,1,50.68 [0-3832253.74],0.493382570040678,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,DKK4,Dickkopf-related protein 4,Inverse variance weighted,15,1.67 [0.39-7.21],0.494491631202851,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,FGL1,Fibrinogen-like protein 1,Inverse variance weighted,7,2.26 [0.21-23.98],0.499797546943649,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,ADGRG1,Adhesion G-protein coupled receptor G1,Inverse variance weighted,4,2.58 [0.16-41.01],0.501024397233955,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,4,2.41 [0.18-31.77],0.503146056917392,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,MFGE8,Lactadherin,Inverse variance weighted,15,0.61 [0.15-2.56],0.50398704183764,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,CD80,T-lymphocyte activation antigen CD80,Inverse variance weighted,10,0.48 [0.05-4.29],0.507286743316848,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,7,0.59 [0.12-2.84],0.509245028023019,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,MFAP4,Microfibril-associated glycoprotein 4,Inverse variance weighted,15,1.49 [0.44-5.03],0.516934392452084,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,5,0.46 [0.04-4.87],0.517647252063206,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,MME,Neprilysin,Inverse variance weighted,46,0.86 [0.54-1.37],0.51927316899796,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,SULT2A1,Bile salt sulfotransferase,Inverse variance weighted,3,0.43 [0.03-5.75],0.523602718717173,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,MUC13,Mucin-13,Inverse variance weighted,3,0.37 [0.02-8.11],0.52892000149878,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,PRSS8,Prostasin,Inverse variance weighted,14,1.55 [0.39-6.2],0.5344095093962,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,YAP1,Transcriptional coactivator YAP1,Inverse variance weighted,9,0.63 [0.15-2.7],0.536662968392334,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,IL1RN,Interleukin-1 receptor antagonist protein,Inverse variance weighted,4,2.53 [0.13-49.59],0.542030142077739,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,6,0.52 [0.06-4.25],0.543801955349423,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,CTSD,Cathepsin D,Inverse variance weighted,7,1.94 [0.22-17.2],0.552284938392433,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,Inverse variance weighted,25,1.29 [0.55-3.06],0.55707774150501,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,NEFL,Neurofilament light polypeptide,Inverse variance weighted,6,0.5 [0.05-5.18],0.558678699010895,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,NT5C1A,Cytosolic 5'-nucleotidase 1A,Inverse variance weighted,4,1.72 [0.28-10.7],0.55964078700569,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,NPL,N-acetylneuraminate lyase,Inverse variance weighted,5,1.61 [0.32-8.1],0.565320637510134,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Inverse variance weighted,19,1.22 [0.61-2.42],0.571681906405845,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,IGFBP4,Insulin-like growth factor-binding protein 4,Inverse variance weighted,3,3.44 [0.05-262],0.575813565303341,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,IGSF8,Immunoglobulin superfamily member 8,Inverse variance weighted,4,0.6 [0.1-3.54],0.576698450615046,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,10,1.5 [0.36-6.2],0.578329874235918,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,RNASE6,Ribonuclease K6,Inverse variance weighted,4,2.46 [0.1-62.14],0.585230244432329,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,MMP7,Matrilysin,Wald ratio,1,1.78 [0.22-14.11],0.586600902859032,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,10,0.81 [0.39-1.72],0.588042491655618,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,PI3,Elafin,Inverse variance weighted,18,1.19 [0.64-2.2],0.589483848141881,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,FAM20A,Pseudokinase FAM20A,Inverse variance weighted,21,1.15 [0.69-1.93],0.590384623798181,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,EGFR,Epidermal growth factor receptor,Inverse variance weighted,8,0.46 [0.03-7.75],0.59243256028646,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,DNER,Delta and Notch-like epidermal growth factor-related receptor,Inverse variance weighted,18,0.74 [0.24-2.25],0.597032755618272,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,2,0.37 [0.01-14.88],0.597054572365802,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,GSN,Gelsolin,Inverse variance weighted,7,1.53 [0.31-7.54],0.598742486347093,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,PLXNB2,Plexin-B2,Inverse variance weighted,12,1.53 [0.31-7.43],0.600956111188977,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,FABP4,"Fatty acid-binding protein, adipocyte",Wald ratio,1,2.12 [0.13-35.82],0.601358629071827,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,8,0.79 [0.32-1.92],0.604186887533094,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Inverse variance weighted,4,0.48 [0.03-7.93],0.60441156740458,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,ADGRD1,Adhesion G-protein coupled receptor D1,Inverse variance weighted,15,1.33 [0.43-4.16],0.618119642193905,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,COL4A1,Collagen alpha-1(IV) chain,Inverse variance weighted,28,0.88 [0.53-1.47],0.624083439758997,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,PVR,Poliovirus receptor,Inverse variance weighted,3,0.43 [0.01-13.89],0.635026716621134,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,CCL16,C-C motif chemokine 16,Inverse variance weighted,26,1.07 [0.8-1.43],0.643999778793592,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,IL1RL1,Interleukin-1 receptor-like 1,Inverse variance weighted,27,0.8 [0.31-2.07],0.644722306293179,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,3,2.22 [0.07-70.04],0.649645904277628,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,PYY,Peptide YY,Inverse variance weighted,16,1.18 [0.57-2.45],0.650872520234254,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,FABP3,"Fatty acid-binding protein, heart",Inverse variance weighted,6,2.02 [0.09-45.48],0.657613447965644,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,PLA2G7,Platelet-activating factor acetylhydrolase,Inverse variance weighted,18,0.83 [0.36-1.92],0.661716508198019,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,24,0.89 [0.51-1.53],0.667640620046742,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,TFF3,Trefoil factor 3,Inverse variance weighted,10,1.32 [0.36-4.85],0.672192655586177,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,CLEC4D,C-type lectin domain family 4 member D,Inverse variance weighted,9,1.31 [0.37-4.59],0.67321706492027,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,3,1.66 [0.15-18.94],0.68448078695721,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,SFRP1,Secreted frizzled-related protein 1,Inverse variance weighted,9,1.4 [0.27-7.24],0.68790589413375,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,AGRN,Agrin,Inverse variance weighted,14,1.25 [0.4-3.89],0.698564976898121,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,GM2A,Ganglioside GM2 activator,Inverse variance weighted,2,0.47 [0.01-21.78],0.701209678676239,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,6,0.46 [0.01-24.75],0.701339036058517,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Inverse variance weighted,4,0.52 [0.02-15.06],0.704087145806105,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,MDK,Midkine,Inverse variance weighted,14,1.26 [0.39-4.07],0.70444534872661,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,SEPTIN8,Septin-8,Inverse variance weighted,4,0.67 [0.09-5.27],0.705101013051586,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,OCLN,Occludin,Inverse variance weighted,2,1.82 [0.08-43.33],0.712529690640763,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,CD14,Monocyte differentiation antigen CD14,Inverse variance weighted,6,1.57 [0.14-17.95],0.716492472904792,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,7,1.57 [0.13-18.54],0.719810585881694,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,OSM,Oncostatin-M,Inverse variance weighted,6,1.38 [0.24-7.94],0.720819959743767,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,ACTA2,"Actin, aortic smooth muscle",Wald ratio,1,0.52 [0.01-21.71],0.73215554949384,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,5,1.54 [0.12-19.46],0.737803774421215,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,4,1.72 [0.07-43.93],0.742184846924721,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,SERPIND1,Heparin cofactor 2,Inverse variance weighted,32,0.9 [0.47-1.72],0.745574600124145,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,3,0.64 [0.04-9.92],0.750365518278164,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,CD59,CD59 glycoprotein,Inverse variance weighted,4,0.69 [0.07-6.72],0.752837286901442,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,AREG,Amphiregulin,Inverse variance weighted,5,1.38 [0.18-10.58],0.754865910646182,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,NHLRC3,NHL repeat-containing protein 3,Inverse variance weighted,5,0.72 [0.09-5.77],0.759401267176814,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,OSCAR,Osteoclast-associated immunoglobulin-like receptor,Inverse variance weighted,7,0.63 [0.03-12.57],0.761400942575494,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,8,0.75 [0.12-4.68],0.761757458630467,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,2,0.53 [0.01-34.6],0.763673965525029,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,FSTL3,Follistatin-related protein 3,Inverse variance weighted,3,0.43 [0-156.12],0.777679793746965,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,2,1.7 [0.04-66.98],0.778373941303667,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,NECTIN2,Nectin-2,Inverse variance weighted,3,0.6 [0.01-25.73],0.787762893153417,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,CLEC14A,C-type lectin domain family 14 member A,Inverse variance weighted,3,1.3 [0.18-9.34],0.79626855503726,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,SIGLEC10,Sialic acid-binding Ig-like lectin 10,Inverse variance weighted,8,1.28 [0.19-8.44],0.798146725051818,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,MMP12,Macrophage metalloelastase,Inverse variance weighted,2,0.61 [0.01-30.77],0.806289584557241,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,SPON2,Spondin-2,Inverse variance weighted,3,1.46 [0.07-30.61],0.806501774058271,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,Inverse variance weighted,48,1.05 [0.71-1.56],0.808258068930857,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,LAYN,Layilin,Inverse variance weighted,3,0.53 [0-88.95],0.810211877026592,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,Inverse variance weighted,3,1.64 [0.03-96.12],0.811054010085792,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,CXCL16,C-X-C motif chemokine 16,Inverse variance weighted,15,1.12 [0.43-2.88],0.818876402326433,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,HYAL1,Hyaluronidase-1,Inverse variance weighted,19,1.07 [0.55-2.1],0.832966585581555,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,8,0.8 [0.1-6.7],0.838451332543781,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,MZB1,Marginal zone B- and B1-cell-specific protein,Inverse variance weighted,18,1.09 [0.47-2.49],0.844272142247881,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,Inverse variance weighted,5,0.83 [0.12-5.69],0.84741079419199,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,EFNA4,Ephrin-A4,Inverse variance weighted,2,1.3 [0.09-18.38],0.847420559627359,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,UMOD,Uromodulin,Inverse variance weighted,34,1.07 [0.51-2.26],0.849045607014702,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,RBP5,Retinol-binding protein 5,Inverse variance weighted,2,1.35 [0.06-32.09],0.851477009062913,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,NELL1,Protein kinase C-binding protein NELL1,Inverse variance weighted,33,0.95 [0.56-1.62],0.856831911356334,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,6,1.15 [0.21-6.23],0.86884625356957,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,12,1.11 [0.33-3.72],0.869229579320829,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,3,0.8 [0.05-12.08],0.875216720310566,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,CCL20,C-C motif chemokine 20,Inverse variance weighted,6,0.89 [0.19-4.1],0.879187756587114,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",Inverse variance weighted,2,0.47 [0-7800],0.880389876964381,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,Inverse variance weighted,22,1.07 [0.41-2.76],0.890855390017664,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,35,0.97 [0.63-1.49],0.896158982601306,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,LGALS9,Galectin-9,Inverse variance weighted,36,0.97 [0.61-1.53],0.897605178729211,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,2,0.82 [0.04-18.46],0.901014562780096,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,AMBP,Protein AMBP,Inverse variance weighted,5,1.1 [0.23-5.21],0.905339698699301,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,TIMP1,Metalloproteinase inhibitor 1,Inverse variance weighted,2,0.85 [0.05-14.1],0.908634371201092,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,THBS2,Thrombospondin-2,Inverse variance weighted,15,1.05 [0.42-2.63],0.917634373698039,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,17,0.96 [0.43-2.14],0.919044464285137,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Wald ratio,1,1.27 [0.01-146.35],0.921757874237709,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,2,0.78 [0-156.86],0.928224089267278,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,CST3,Cystatin-C,Inverse variance weighted,3,1.14 [0.05-24.35],0.932296780390049,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,SHISA5,Protein shisa-5,Inverse variance weighted,12,1.07 [0.21-5.62],0.932352820037263,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,32,0.97 [0.48-1.98],0.938510977696079,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,RNASE4,Ribonuclease 4,Inverse variance weighted,2,1.2 [0.01-168.6],0.942491911020495,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,Inverse variance weighted,4,1.04 [0.35-3.09],0.943003248320045,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,IL15,Interleukin-15,Inverse variance weighted,35,1.02 [0.51-2.04],0.94505397447578,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,6,0.94 [0.15-5.78],0.945578822507219,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,6,1.05 [0.2-5.66],0.951109568370524,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,SCG2,Secretogranin-2,Inverse variance weighted,2,0.92 [0.05-15.69],0.95430691369648,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",Wald ratio,1,1.17 [0-280.23],0.954520000018307,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,F9,Coagulation factor IX,Inverse variance weighted,3,0.86 [0-167.91],0.956583177920065,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,NOS3,"Nitric oxide synthase, endothelial",Inverse variance weighted,5,0.91 [0.03-32.4],0.95710592976614,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,GRPEL1,"GrpE protein homolog 1, mitochondrial",Inverse variance weighted,2,0.94 [0.06-15.48],0.963635637081848,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,GRN,Progranulin,Inverse variance weighted,46,1.01 [0.69-1.48],0.965816112132194,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,KRT19,"Keratin, type I cytoskeletal 19",Inverse variance weighted,5,0.97 [0.24-3.96],0.971402498755948,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",Wald ratio,1,1.09 [0.01-154.71],0.971418221381774,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,CTSL,Cathepsin L1,Inverse variance weighted,29,1.01 [0.48-2.12],0.971476782635833,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,RARRES2,Retinoic acid receptor responder protein 2,Inverse variance weighted,2,1.05 [0.03-34.69],0.976600996923588,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,TFF1,Trefoil factor 1,Inverse variance weighted,14,0.99 [0.51-1.92],0.97908912031995,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,REN,Renin,Inverse variance weighted,8,0.99 [0.19-5.06],0.988653087290198,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,CA9,Carbonic anhydrase 9,Inverse variance weighted,8,0.99 [0.2-4.83],0.993620273869306,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",Inverse variance weighted,2,1.01 [0.03-32.8],0.994319058395332,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,TGFA,Protransforming growth factor alpha,Inverse variance weighted,9,1 [0.14-7.03],0.996936924546976,trans
